Donor Simvastatin Treatment Alters the Gene Expression Profile of Human Cardiac Allografts During Ischemia and Reperfusion: ISHLT 38th Annual Meeting and Scientific Sessions
Journal of Heart and Lung Transplantation(2018)
Abstract
Recently, we were able to show in a randomized clinical trial that simvastatin treatment of brain-dead donors reduces ischemia-reperfusion injury in human cardiac allograft recipients. Here, we analyze myocardial transcriptome changes in cardiac allografts after donor simvastatin treatment.
MoreTranslated text
Key words
donor simvastatin treatment alters,human cardiac allografts,ischemia
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined